TNXP Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.03%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Tonix Pharmaceuticals Insider Trading History Chart

Tonix Pharmaceuticals Share Price & Price History

^$19.77

▼ -0.23 (-1.15%)

As of 05/5/2025 04:21 PM ET

Days: 30 | 90 | 365

Tonix Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
6/29/2022	Seth Lederman	CEO	Buy	1	$34,200.00	$34,200.00	1

SEC Filings (Institutional Ownership Changes) for Tonix Pharmaceuticals (NASDAQ:TNXP)

82.26% of Tonix Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Tonix Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/8/2025	Rhumbline Advisers	13,670	$0.24M	0.0%	N/A	0.212%
2/17/2025	Two Sigma Investments LP	200,797	$66K	0.0%	N/A	10.738%
2/17/2025	Point72 Asset Management L.P.	1,596,344	$0.53M	0.0%	N/A	85.366%
2/17/2025	Millennium Management LLC	284,123	$94K	0.0%	-21.4%	15.194%
2/14/2025	Jane Street Group LLC	1,662,682	$0.55M	0.0%	+5,932.3%	88.961%
2/14/2025	Northern Trust Corp	489,735	$0.16M	0.0%	N/A	26.203%
2/12/2025	Geode Capital Management LLC	1,971,894	$0.65M	0.0%	+1,600.1%	105.449%
2/10/2025	Commonwealth Equity Services LLC	120,292	$40K	0.0%	N/A	6.433%
1/22/2025	PFG Investments LLC	218,003	$72K	0.0%	N/A	0.117%
8/6/2024	Acadian Asset Management LLC	57,762	$39K	0.0%	-82.8%	1.934%
5/10/2024	Acadian Asset Management LLC	335,373	$61K	0.0%	+260.6%	0.397%
2/13/2024	Armistice Capital LLC	3,770,000	$1.52M	0.0%	+160.0%	14.088%
11/15/2023	Sabby Management LLC	1,247,465	$0.68M	0.5%	N/A	7.024%
11/15/2023	Armistice Capital LLC	1,450,000	$0.79M	0.0%	N/A	8.164%
8/7/2023	Acadian Asset Management LLC	68,743	$0.11M	0.0%	-57.1%	0.639%
7/25/2023	Raymond James & Associates	44,364	$70K	0.0%	-83.3%	0.429%
5/1/2023	Virtu Financial LLC	58,883	$35K	0.0%	-68.7%	0.094%
4/14/2023	Raymond James & Associates	266,188	$0.16M	0.0%	+58.4%	0.425%
2/15/2023	Tang Capital Management LLC	4,500,419	$1.75M	0.3%	N/A	7.822%
11/7/2022	Virtu Financial LLC	129,891	$69K	0.0%	N/A	0.290%
5/11/2022	GSA Capital Partners LLP	1,887,989	$0.44M	0.1%	+6.0%	0.354%
5/10/2022	Edmond DE Rothschild Holding S.A.	300,000	$69K	0.0%	+200.0%	0.056%
2/14/2022	Point72 Hong Kong Ltd	348,383	$0.13M	0.0%	+3,344.6%	0.070%
2/14/2022	GSA Capital Partners LLP	1,781,617	$0.64M	0.1%	+245.1%	0.359%
2/11/2022	Renaissance Technologies LLC	10,699,831	$3.83M	0.0%	+77.2%	2.156%
2/9/2022	Alps Advisors Inc.	548,866	$0.20M	0.0%	N/A	0.111%
2/8/2022	ProShare Advisors LLC	158,760	$57K	0.0%	+243.6%	0.032%
2/8/2022	Northern Trust Corp	3,839,725	$1.38M	0.0%	+17.9%	0.774%
2/7/2022	SG Americas Securities LLC	156,743	$56K	0.0%	-31.7%	0.032%
11/15/2021	GSA Capital Partners LLP	516,218	$0.31M	0.0%	-23.7%	0.144%
11/12/2021	Renaissance Technologies LLC	6,038,664	$3.63M	0.0%	-16.2%	1.689%
11/12/2021	The Manufacturers Life Insurance Company	236,958	$0.14M	0.0%	+20.5%	0.066%
11/12/2021	Geode Capital Management LLC	7,423,326	$4.46M	0.0%	+34.4%	2.076%
11/10/2021	Goldman Sachs Group Inc.	616,135	$0.37M	0.0%	+1,755.8%	0.172%
11/10/2021	Citigroup Inc.	46,217	$28K	0.0%	+197.3%	0.013%
11/9/2021	BlackRock Inc.	27,321,653	$16.42M	0.0%	+3.1%	7.642%
11/9/2021	Principal Financial Group Inc.	93,387	$56K	0.0%	-17.0%	0.026%
11/8/2021	State Board of Administration of Florida Retirement System	175,630	$0.11M	0.0%	N/A	0.049%
11/4/2021	Deutsche Bank AG	374,147	$0.23M	0.0%	+92.9%	0.105%
11/2/2021	New York State Common Retirement Fund	187,026	$0.11M	0.0%	-33.2%	0.052%
11/1/2021	SG Americas Securities LLC	229,611	$0.14M	0.0%	+1,670.2%	0.064%
10/28/2021	WINTON GROUP Ltd	61,977	$37K	0.0%	-49.6%	0.017%
9/17/2021	Virtu Financial LLC	294,771	$0.33M	0.0%	N/A	0.082%
9/3/2021	Parametric Portfolio Associates LLC	65,249	$72K	0.0%	N/A	0.018%
8/17/2021	Metropolitan Life Insurance Co NY	103,289	$0.12M	0.0%	N/A	0.029%
8/17/2021	Millennium Management LLC	830,208	$0.92M	0.0%	-15.7%	0.232%
8/17/2021	MetLife Investment Management LLC	134,908	$0.15M	0.0%	N/A	0.038%
8/17/2021	Price T Rowe Associates Inc. MD	26,257	$29K	0.0%	N/A	0.007%
8/17/2021	Bridgeway Capital Management LLC	214,500	$0.24M	0.0%	-18.9%	0.060%
8/16/2021	AQR Capital Management LLC	241,469	$0.27M	0.0%	N/A	0.068%
8/16/2021	Amalgamated Bank	45,980	$51K	0.0%	N/A	0.013%
8/16/2021	California State Teachers Retirement System	450,799	$0.50M	0.0%	N/A	0.126%
8/16/2021	First Trust Advisors LP	172,793	$0.19M	0.0%	-20.6%	0.048%
8/16/2021	Charles Schwab Investment Management Inc.	818,869	$0.91M	0.0%	+548.5%	0.229%
8/16/2021	State Street Corp	5,097,793	$5.66M	0.0%	+6,469.3%	1.426%
8/16/2021	Nuveen Asset Management LLC	1,746,116	$1.94M	0.0%	N/A	0.488%
8/13/2021	Renaissance Technologies LLC	7,203,677	$8M	0.0%	-14.8%	2.015%
8/13/2021	Northern Trust Corp	3,108,226	$3.45M	0.0%	+389.1%	0.869%
8/13/2021	Geode Capital Management LLC	5,521,734	$6.13M	0.0%	+90.6%	1.544%
8/13/2021	Vanguard Group Inc.	15,766,539	$17.50M	0.0%	+7.4%	4.410%
8/13/2021	ProShare Advisors LLC	84,752	$94K	0.0%	N/A	0.024%
8/12/2021	Legal & General Group Plc	26,086	$29K	0.0%	N/A	0.008%
8/12/2021	JPMorgan Chase & Co.	125,422	$0.14M	0.0%	N/A	0.038%
8/12/2021	The Manufacturers Life Insurance Company	196,601	$0.22M	0.0%	N/A	0.060%
8/11/2021	Bank of New York Mellon Corp	965,153	$1.07M	0.0%	+489.2%	0.293%
8/11/2021	BlackRock Inc.	26,501,101	$29.42M	0.0%	+248.6%	8.049%
8/11/2021	Deutsche Bank AG	193,948	$0.22M	0.0%	N/A	0.059%
8/10/2021	Principal Financial Group Inc.	112,476	$0.13M	0.0%	+288.7%	0.034%
8/10/2021	WINTON GROUP Ltd	122,987	$0.14M	0.0%	N/A	0.037%
8/6/2021	Ameritas Investment Partners Inc.	25,614	$28K	0.0%	N/A	0.008%
8/6/2021	Nisa Investment Advisors LLC	41,750	$46K	0.0%	N/A	0.013%
8/5/2021	Rhumbline Advisers	322,189	$0.36M	0.0%	N/A	0.098%
8/5/2021	GSA Capital Partners LLP	676,761	$0.75M	0.1%	+56.5%	0.206%
8/2/2021	New York State Common Retirement Fund	279,900	$0.31M	0.0%	N/A	0.085%
7/30/2021	Alliancebernstein L.P.	202,200	$0.22M	0.0%	N/A	0.061%
5/18/2021	Millennium Management LLC	984,451	$1.26M	0.0%	N/A	0.302%
5/18/2021	Cubist Systematic Strategies LLC	20,801	$27K	0.0%	N/A	0.006%
5/18/2021	Citadel Advisors LLC	606,189	$0.78M	0.0%	N/A	0.184%
5/17/2021	Edmond DE Rothschild Holding S.A.	100,000	$0.13M	0.0%	N/A	0.031%
5/17/2021	HRT Financial LP	347,816	$0.45M	0.0%	N/A	0.107%
5/17/2021	Goldman Sachs Group Inc.	251,740	$0.32M	0.0%	N/A	0.077%
5/13/2021	Renaissance Technologies LLC	8,454,364	$10.82M	0.0%	+3,017.8%	2.589%
5/13/2021	Bank of New York Mellon Corp	163,815	$0.21M	0.0%	N/A	0.050%
5/12/2021	Northern Trust Corp	635,539	$0.81M	0.0%	+141.7%	0.195%
5/12/2021	Cerity Partners LLC	20,300	$26K	0.0%	N/A	0.006%
5/12/2021	Geode Capital Management LLC	2,896,717	$3.71M	0.0%	+213.2%	0.887%
5/12/2021	Grimes & Company Inc.	20,700	$26K	0.0%	N/A	0.006%
5/10/2021	HighTower Advisors LLC	26,335	$33K	0.0%	-44.4%	0.008%
5/10/2021	GSA Capital Partners LLP	432,503	$0.55M	0.1%	-62.1%	0.132%
5/7/2021	BlackRock Inc.	7,602,535	$9.73M	0.0%	+416.6%	2.328%
5/4/2021	Victory Capital Management Inc.	52,625	$67K	0.0%	+64.0%	0.016%

Data available starting January 2016

See Full Table

Tonix Pharmaceuticals Holding Corp., a biopharmaceutical company, focuses on developing, discovering, commercializing, and licensing therapeutics to treat and prevent human disease and alleviate suffering. It markets Zembrace SymTouch and Tosymra for the treatment of acute migraine with or without aura in adults. Its portfolio focuses on central nervous system disorders, as well as rare disease, immunology, and infectious disease product candidates. The company's priority is to submit a New Drug Application (NDA) to the FDA for TNX-102 SL (cyclobenzaprine HCl sublingual tablet), which has completed two positive Phase 3 studies for the management of fibromyalgia. TNX-102 SL is also being developed to treat fibromyalgia-type Long COVID, a chronic post-acute COVID-19 condition. Its TNX-1300 (cocaine esterase) is a biologic designed to treat cocaine intoxication and has been granted breakthrough therapy designation by the FDA. The company's rare disease development portfolio comprises TNX-2900, an intranasal potentiated oxytocin for the treatment of Prader-Willi syndrome (PWS). Its immunology portfolio includes TNX-1500, which is a biologic to address organ transplant rejection and autoimmune diseases. The company's infectious disease pipeline includes TNX-801, a vaccine in development to prevent smallpox and mpox. TNX-801 also serves as the live virus vaccine platform or recombinant pox vaccine platform for other infectious diseases, including TNX-1800 and TNX-1850, in development as a vaccine to protect against COVID-19. Its infectious disease development portfolio also comprises TNX-3900, and TNX-4200 are orally available CD45 antagonists in preclinical development. Tonix Pharmaceuticals Holding Corp. has collaboration agreement with Bilthoven Biologicals to advance TNX-801 mpox vaccine candidate; and with X-Chem, Inc. to develop broad-spectrum antivirals. The company was founded in 2007 and is headquartered in Chatham, New Jersey.

Today's Range

Now: $19.77

$19.58

$21.99

50 Day Range

MA: $16.88

$7.38

$30.51

52 Week Range

Now: $19.77

$6.76

$672.00

Volume

907,958 shs

Average Volume

792,153 shs

Market Capitalization

$127.22 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.5

Who are the major institutional investors of Tonix Pharmaceuticals?: Tonix Pharmaceuticals' top institutional shareholders include:
Rhumbline Advisers — 0.21%
Learn More about top institutional investors of Tonix Pharmaceuticals stock.
Which institutional investors are buying Tonix Pharmaceuticals stock?: In the previous quarter, TNXP stock was bought by institutional investors including:
Rhumbline Advisers